Market Tracker

10/30 12:37pm ET
241.09
Real-Time Quote
 +2.31 / +0.97%
Today’s Change
153.42
Today|||52-Week Range
249.94
+43.51%
Year-to-Date

Today’s Trading

Previous close238.78
Today’s open238.36
Day’s range237.36 - 241.55
Volume662,116
Average volume (3 months)2,419,484
Market cap$63.1B
Dividend yield--
Data as of 12:22pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+40.02%
Earnings growth (next 5 years)+18.41%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.36

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.58+1.36%
AGNAllergan Inc+1.61+0.86%
LLYEli Lilly and Co+1.04+1.59%
VRXValeant Pharmaceutic...+1.09+0.84%
Data as of 12:36pm ET, 10/30/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$3.11
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts